Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/GW_Pharmaceuticals> ?p ?o }
- GW_Pharmaceuticals abstract "GW Pharmaceuticals is a British biopharmaceutical company known for its multiple sclerosis treatment product Sativex, nabiximols (brand name, Sativex). Sativex is the first natural cannabis plant derivative to gain market approval in any country. Another cannabis-based product, Epidiolex, for treatment of epilepsy, underwent phase 3 clinical trials in 2015.".
- GW_Pharmaceuticals foundingYear "1998".
- GW_Pharmaceuticals location Porton_Down.
- GW_Pharmaceuticals revenue "3.38E7".
- GW_Pharmaceuticals type Public_limited_company.
- GW_Pharmaceuticals wikiPageExternalLink The_Medicinal_Uses_of_Cannabis_and_Canna.html?id=AznCzOxvrtwC.
- GW_Pharmaceuticals wikiPageExternalLink www.gwpharm.com.
- GW_Pharmaceuticals wikiPageID "36476338".
- GW_Pharmaceuticals wikiPageLength "10105".
- GW_Pharmaceuticals wikiPageOutDegree "44".
- GW_Pharmaceuticals wikiPageRevisionID "703250930".
- GW_Pharmaceuticals wikiPageWikiLink Bayer.
- GW_Pharmaceuticals wikiPageWikiLink Biopharmaceutical.
- GW_Pharmaceuticals wikiPageWikiLink Botanical_drug.
- GW_Pharmaceuticals wikiPageWikiLink Cannabidiol.
- GW_Pharmaceuticals wikiPageWikiLink Cannabis.
- GW_Pharmaceuticals wikiPageWikiLink Cannabis_(drug).
- GW_Pharmaceuticals wikiPageWikiLink Cannabis_strains.
- GW_Pharmaceuticals wikiPageWikiLink Carbon_dioxide.
- GW_Pharmaceuticals wikiPageWikiLink Category:Bayer_brands.
- GW_Pharmaceuticals wikiPageWikiLink Category:Biotechnology_companies_of_the_United_Kingdom.
- GW_Pharmaceuticals wikiPageWikiLink Category:Cannabis_companies.
- GW_Pharmaceuticals wikiPageWikiLink Category:Cannabis_in_the_United_Kingdom.
- GW_Pharmaceuticals wikiPageWikiLink Category:Cannabis_research.
- GW_Pharmaceuticals wikiPageWikiLink Category:Companies_listed_on_NASDAQ.
- GW_Pharmaceuticals wikiPageWikiLink Category:Companies_listed_on_the_London_Stock_Exchange.
- GW_Pharmaceuticals wikiPageWikiLink Category:Medicinal_use_of_cannabis_organizations.
- GW_Pharmaceuticals wikiPageWikiLink Category:Pharmaceutical_companies_established_in_1998.
- GW_Pharmaceuticals wikiPageWikiLink Category:Pharmaceutical_companies_of_the_United_Kingdom.
- GW_Pharmaceuticals wikiPageWikiLink Dravet_syndrome.
- GW_Pharmaceuticals wikiPageWikiLink Epilepsy.
- GW_Pharmaceuticals wikiPageWikiLink Ethanol.
- GW_Pharmaceuticals wikiPageWikiLink FDA_Fast_Track_Development_Program.
- GW_Pharmaceuticals wikiPageWikiLink Home_Office.
- GW_Pharmaceuticals wikiPageWikiLink Hortapharm_B.V..
- GW_Pharmaceuticals wikiPageWikiLink Horticulture.
- GW_Pharmaceuticals wikiPageWikiLink Lennox–Gastaut_syndrome.
- GW_Pharmaceuticals wikiPageWikiLink Medical_cannabis.
- GW_Pharmaceuticals wikiPageWikiLink Medicines_and_Healthcare_Products_Regulatory_Agency.
- GW_Pharmaceuticals wikiPageWikiLink Multiple_sclerosis.
- GW_Pharmaceuticals wikiPageWikiLink Nabilone.
- GW_Pharmaceuticals wikiPageWikiLink Nabiximols.
- GW_Pharmaceuticals wikiPageWikiLink Neuropathic_pain.
- GW_Pharmaceuticals wikiPageWikiLink Phases_of_clinical_research.
- GW_Pharmaceuticals wikiPageWikiLink Porton_Down.
- GW_Pharmaceuticals wikiPageWikiLink Public_limited_company.
- GW_Pharmaceuticals wikiPageWikiLink Rare_disease.
- GW_Pharmaceuticals wikiPageWikiLink Spasticity.
- GW_Pharmaceuticals wikiPageWikiLink Tetrahydrocannabinol.
- GW_Pharmaceuticals wikiPageWikiLinkText "GW Pharmaceuticals".
- GW_Pharmaceuticals wikiPageWikiLinkText "GW".
- GW_Pharmaceuticals divisions "Biotechnology".
- GW_Pharmaceuticals foundation "1998".
- GW_Pharmaceuticals founder "Geoffrey Guy and Brian Whittle".
- GW_Pharmaceuticals industry "Pharmaceutical".
- GW_Pharmaceuticals keyPeople "Justin Gover".
- GW_Pharmaceuticals location Porton_Down.
- GW_Pharmaceuticals locationCountry "United Kingdom".
- GW_Pharmaceuticals name "GW Pharmaceuticals PLC".
- GW_Pharmaceuticals products "Sativex®".
- GW_Pharmaceuticals revenue "3.38E7".
- GW_Pharmaceuticals type Public_limited_company.
- GW_Pharmaceuticals wikiPageUsesTemplate Template:EngvarB.
- GW_Pharmaceuticals wikiPageUsesTemplate Template:Infobox_company.
- GW_Pharmaceuticals wikiPageUsesTemplate Template:LSE.
- GW_Pharmaceuticals wikiPageUsesTemplate Template:Main.
- GW_Pharmaceuticals wikiPageUsesTemplate Template:NASDAQ.
- GW_Pharmaceuticals wikiPageUsesTemplate Template:Pharmaceutical_industry_in_the_United_Kingdom.
- GW_Pharmaceuticals wikiPageUsesTemplate Template:Reflist.
- GW_Pharmaceuticals wikiPageUsesTemplate Template:Science_and_technology_in_the_United_Kingdom.
- GW_Pharmaceuticals wikiPageUsesTemplate Template:Url.
- GW_Pharmaceuticals wikiPageUsesTemplate Template:Use_dmy_dates.
- GW_Pharmaceuticals subject Category:Bayer_brands.
- GW_Pharmaceuticals subject Category:Biotechnology_companies_of_the_United_Kingdom.
- GW_Pharmaceuticals subject Category:Cannabis_companies.
- GW_Pharmaceuticals subject Category:Cannabis_in_the_United_Kingdom.
- GW_Pharmaceuticals subject Category:Cannabis_research.
- GW_Pharmaceuticals subject Category:Companies_listed_on_NASDAQ.
- GW_Pharmaceuticals subject Category:Companies_listed_on_the_London_Stock_Exchange.
- GW_Pharmaceuticals subject Category:Medicinal_use_of_cannabis_organizations.
- GW_Pharmaceuticals subject Category:Pharmaceutical_companies_established_in_1998.
- GW_Pharmaceuticals subject Category:Pharmaceutical_companies_of_the_United_Kingdom.
- GW_Pharmaceuticals hypernym Company.
- GW_Pharmaceuticals type Agent.
- GW_Pharmaceuticals type Company.
- GW_Pharmaceuticals type Organisation.
- GW_Pharmaceuticals type Brand.
- GW_Pharmaceuticals type Company.
- GW_Pharmaceuticals type Establishment.
- GW_Pharmaceuticals type Organization.
- GW_Pharmaceuticals type Agent.
- GW_Pharmaceuticals type SocialPerson.
- GW_Pharmaceuticals type Thing.
- GW_Pharmaceuticals type Q43229.
- GW_Pharmaceuticals comment "GW Pharmaceuticals is a British biopharmaceutical company known for its multiple sclerosis treatment product Sativex, nabiximols (brand name, Sativex). Sativex is the first natural cannabis plant derivative to gain market approval in any country. Another cannabis-based product, Epidiolex, for treatment of epilepsy, underwent phase 3 clinical trials in 2015.".
- GW_Pharmaceuticals label "GW Pharmaceuticals".
- GW_Pharmaceuticals sameAs Q3093459.
- GW_Pharmaceuticals sameAs GW_Pharmaceuticals.
- GW_Pharmaceuticals sameAs m.0k967d3.
- GW_Pharmaceuticals sameAs Q3093459.